RxDoctor Payments Data

Clancy Cone

Internal Medicine · Missoula, MTNPI 1366421620

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Novo Nordisk at 50.8% of the total.

$192in general payments, 2019–2025

Across 7 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$97
  • Pfizer$31
  • Astellas Pharma US Inc$23
  • Merck$23
  • AstraZeneca$17
$2,575,233in research payments, 2019–2025

Across 1,030 payments — averaging $2500.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.7M
  • Eli Lilly$172K
  • GSK$139K
  • AstraZeneca$129K
  • AbbVie$113K
  • Radius Health, Inc.$76K
  • plus $225K from 7 others

What the payments were for

  • Food & beverage$192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk1$97
Pfizer2$31
Astellas Pharma US Inc1$23
Merck2$23
AstraZeneca1$17

How this compares

$192 in reported general payments places this provider in the 75th percentile of 244 internal medicine providers in Montana.

See all internal medicine providers in Montana →

Other internal medicine in Missoula

See the full list for Montana →

Where these figures come from

Is this you, or does something look wrong? →